glp 1 drugs and high blood pressure GLP-1 Hypertension: A New Edge in Control GLP-1 drugs tied to elevated

But without insurance, these drugs are prohibitively expensive, especially the name-brand ones

A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37) Journal of Biological Chemistry

Endocrinology 152 (9), 33623372 (2011)

Abstract Aims/hypothesis We aimed to determine whether the use of glucagon-like peptide-1 receptor agonists (GLP-1RA) in individuals with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus decreases the risk of new-onset adverse cardiovascular events (CVEs) and mortality rate compared with other glucose-lowering drugs in a real setting at a population level

10.2337/dc14-2365 [DOI] [PubMed] [Google Scholar] 84.DeFronzo RA, Lewin A, Patel S, Liu D, Kaste R, Woerle HJ, et al

Endocrine Related Cancer , 19 (5), F77